Close Menu

Proteome Sciences

Growth initiatives for 2011 include the hiring of additional business development and sales staff, development of assays for cancer and Alzheimer's disease, and expansion of the plexing rates for its TMT reagents.

The new guidelines mark the second publication in recent months to suggest that protein biomarkers be integrated into current definitions of Alzheimer's disease, though the new proposal explicitly calls for protein biomarkers to be used only in research settings.

Under the deal, which follows on a similar 2009 agreement between the firms, Proteome Sciences will provide Takeda with mass spec-based assays for the discovery and validation of protein biomarkers tied to various undisclosed diseases.

Takeda will use the PS Biomarker Services for the development of mass spectrometry-based assays for disease-related proteins.

The agreement calls for Proteome Sciences to quantify plasma levels of the nine proteins in its AD-TMT-SRM panel, which uses multiple-reaction-monitoring mass spectrometry and the company's Tandem Mass Tagging technology.

Under a deal announced today, Proteome Sciences will measure candidate biomarkers for Alzheimer's disease for Eisai.

Movers & Shakers: Jan 28, 2011


Kenneth Fang, Alf Lindberg, Catherin Derasp

Proteome Sciences will provide biomarker analysis services for the J&J company.

Proteome Sciences will provide Icon's clients with its expertise in single-reaction monitoring mass spectrometry, said a company official. The partners' first joint project is the development of an SRM assay measuring a biomarker for an unnamed drugmaker.

The firms plan to offer an integrated biomarker services solution for pharmaceutical candidate development.


The nonprofit Biden Cancer Initiative is suspending its operations, according to the Associated Press.

Researchers examine how white nationalists handle personal genetic ancestry results that conflict with their racist worldview, the New York Times reports.

NPR speaks with research participants before and after they learn their APOE E4 status, which affects their risk of developing Alzheimer's disease.

In PLOS this week: genetic characterization of Toxoplasma gondii strains, Crimean-Congo Hemorrhagic Fever Virus uncovered in Sudan, and more.